Homepage
Full 18-step deep-dive · ~20–30 min · a member feature.
No report run on this ticker yet
Only preliminary foundational data below
Sign in to run a fresh report
Free · results in ~10 min
For AI assistants & researchers — machine-readable summary of this page
What this page is: Delvantic's full research page for Encompass Health Corporation (EHC) — AI-driven forensic equity research: mechanical valuation models (DCF, EPV, anchored-PE, scenario) plus three independent AI lenses (Quality / Value / Sentiment). Everything below is rendered server-side; you are not missing content that requires JavaScript. All scores are predictions and research opinions, not financial advice.
Page map (sections in order; each card carries a stable
reference-name attribute you can cite):
profile-header/price-overview— company profile, live quote, market capextended-analysis— the core: three AI lens reads with findings, scores, and the analyst memofuture-predictions— our forward price-band predictionsmarket-narrative/ai-findings/gpt-critique— narrative context, cross-model findings, and an adversarial critique of our own analysis (near the end of the document)- Members-only sections (render as login gates for anonymous readers):
price-history,income-trend,key-metrics,financials(statement tables),insider-trading. The analysis above is public; the raw data tables require a free account.
More for machine readers: site briefing at
/llms.txt ·
any ticker resolves at delvantic.com/stock/TICKER ·
raw inputs are public-company filings and market data (via licensed data feeds);
every model, score, lens read, and prediction on this page is Delvantic's own analysis.
Encompass Health Corporation
EHC NYSE
Healthcare · Medical Care Facilities
Birmingham, AL 35242, United States
encompasshealth.com
Price
$124.83
Market Cap
$12.3B
Employees
29,699
Beta
0.60
Avg Volume
957,022
Last Dividend
$0.76
CEO
Mr. Mark J. Tarr
Encompass Health Corporation is a prominent American healthcare services company specializing in providing facility-based and home-based post-acute healthcare services. The organization operates through its network of inpatient rehabilitation hospitals, home health agencies, and hospice agencies across the United States. Encompass Health is dedicated to delivering high-quality, cost-effective care focused on enhancing patient outcomes following severe illnesses, surgeries, or injuries. The company plays a crucial role in the healthcare sector, particularly in rehabilitation and post-acute care, addressing the growing demand for comprehensive recovery solutions. Encompass Health Corporation is integral to the healthcare market, ensuring seamless patient transitions from hospital settings to recovery and long-term care, thereby contributing to the overall efficiency and modernization of the healthcare delivery system.
Runs with full report
Earnings Schedule
Checked daily · calendar updated Aug 13 No upcoming print on the calendar yet — companies typically confirm a few weeks ahead. Last print was Jul 30, 2026.
EPS surprise history — vs analyst consensus · 4 prints of vendor history
+3.4%
Oct '25
+12.3%
Feb '26
+7.4%
Apr '26
+4.4%
Jul '26
| Print date | EPS est. | EPS actual | Revenue est. | Revenue actual |
|---|---|---|---|---|
| Jul 30, 2026 | $2.51 | $2.62 +4.4% | — | — |
| Apr 30, 2026 | $1.49 | $1.60 +7.4% | — | — |
| Feb 5, 2026 | $1.30 | $1.46 +12.3% | — | — |
| Oct 29, 2025 | $1.19 | $1.23 +3.4% | — | — |
Green = beat the estimate, red = missed. An earnings print is the fastest way a thesis changes — our designations should be re-read after each one.
Recent SEC Filings
Last updated: Aug 13, 2026 6:28am (7h ago)| Filed | Form | Document |
|---|---|---|
| Aug 11, 2026 | 4 | View |
| Aug 11, 2026 | 4 | View |
| Aug 11, 2026 | 4 | View |
| Aug 10, 2026 | 144 | View |
| Aug 10, 2026 | 144 | View |
| Aug 10, 2026 | 144 | View |
| Aug 7, 2026 | 10-Q | View |
| Aug 5, 2026 | 8-K | View |
| Jul 31, 2026 | SCHEDULE 13G/A | View |
| Jul 16, 2026 | 4 | View |
| Jul 16, 2026 | 4 | View |
| Jul 16, 2026 | 4 | View |
Filings link to the SEC’s EDGAR system. Annual/quarterly reports (10-K, 10-Q, 20-F) carry the full story; 8-K/6-K current reports are the fastest signal that something material happened.
Price Overview
Last updated: Aug 13, 2026 2:18pm (just now)
Current data · timestamped when a report runs
$124.14
Change · Aug 13
-0.69 (-0.55%)
Day Range
$123.54 – $125.98
52-Week Range
$92.77 – $127.99
50-Day MA
$108.76
200-Day MA
$106.90
Volume
22,359.00
Share Structure
Outstanding
98,800,000.00
Float
94,947,963.00
Free Float
96.1%
High free float
— 96.1% of shares trade freely, ~3.9% held by insiders/institutions
Very liquid — most shares trade freely. Low insider ownership can mean less management alignment, but makes large position sizing straightforward.
Price History (1 Year)
Revenue & Net Income Trend
The directional story — useful even when net income is negative.
Revenue
The top line — total sales before any costs or taxes are subtracted. A measure of how much business the company is doing.
Net Income
The bottom line — profit left after subtracting all expenses, interest, and taxes from revenue. Reflects accounting profitability, but includes non-cash items like depreciation, so it isn't the same as cash earned.
Operating Cash Flow
The real cash generated by the day-to-day business — selling products, paying suppliers, collecting from customers. Calculated from net income by adding back non-cash items and adjusting for timing (unpaid bills, unsold inventory). When OCF consistently lags net income, the reported profit may not be converting to real money.
| Period | Revenue | Net Income | Net Margin | YoY/QoQ |
|---|
Key Metrics
TD Twelve Data statement
HEX SEC filing
P/E Ratio (Price per dollar of earnings)
HEXStock Price / EPS (Diluted)
22.53
Stock Price: $124.83
EPS (Diluted): 5.54
EPS (Diluted): 5.54
P/B Ratio (Price vs net asset value)
HEXStock Price / Book Value Per Share
3.89
Stock Price: $124.83
Total Equity: $3.28B
Shares: 102,200,000
Total Equity: $3.28B
Shares: 102,200,000
EV/EBITDA (Total value vs operating profit)
HEXEnterprise Value / EBITDA
—
Market Cap: $12.31B
Total Debt: $0.00
Cash: $72.20M
EBITDA: N/A
Total Debt: $0.00
Cash: $72.20M
EBITDA: N/A
EBITDA not available
Enterprise Value (Takeover price (cap + debt - cash))
HEXMarket Cap + Total Debt - Cash
$12.3B
Market Cap: $12.31B
Total Debt: $0.00
Cash: $72.20M
Total Debt: $0.00
Cash: $72.20M
Gross Margin (Revenue left after direct costs)
HEXGross Profit / Revenue
—
Gross Profit: N/A
Revenue: $5.94B
Revenue: $5.94B
Missing from API: Gross Profit
Operating Margin (Revenue left after all operations)
HEXOperating Income / Revenue
—
Operating Income: N/A
Revenue: $5.94B
Revenue: $5.94B
Missing from API: Operating Income
Net Margin (Revenue left as actual profit)
HEXNet Income / Revenue
9.5%
Net Income: $566.20M
Revenue: $5.94B
Revenue: $5.94B
ROE (Profit from shareholder equity)
HEXNet Income / Total Equity
17.3%
Net Income: $566.20M
Total Equity: $3.28B
Total Equity: $3.28B
ROIC (Profit from all invested capital)
HEXNOPAT / Invested Capital
—
Operating Income: N/A
Tax Rate: 20.2%
Equity: $3.28B
Total Debt: $0.00
Cash: $72.20M
Tax Rate: 20.2%
Equity: $3.28B
Total Debt: $0.00
Cash: $72.20M
Zero debt — invested capital = equity minus cash (very efficient)
Current Ratio (Can it pay short-term bills)
HEXCurrent Assets / Current Liabilities
1.08
Current Assets: $905.90M
Current Liabilities: $836.40M
Current Liabilities: $836.40M
Debt/Equity (Leverage — debt vs equity)
HEXTotal Debt / Total Equity
0.00
Short-Term Debt: $0.00
Long-Term Debt: $0.00
Total Debt: $0.00
Total Equity: $3.28B
Long-Term Debt: $0.00
Total Debt: $0.00
Total Equity: $3.28B
Zero debt — this company carries no debt obligations. Strongest possible score.
Rev/Share (Top-line per share)
HEXRevenue / Shares Outstanding
$58.07
Revenue: $5.94B
Shares: 102,200,000
Shares: 102,200,000
Book Value/Share (Net assets per share)
HEX(Total Assets - Total Liabilities) / Shares
$32.05
Total Equity: $3.28B
Shares: 102,200,000
Shares: 102,200,000
FCF/Share (Real cash generated per share)
HEX(Operating Cash Flow + CapEx) / Shares
$4.30
Operating CF: $1.18B
CapEx: -$736.40M
Shares: 102,200,000
CapEx: -$736.40M
Shares: 102,200,000
CapEx is negative (outflow) — added to OCF to get FCF
Div Yield (Annual income from holding)
TDLast Annual Dividend / Stock Price
0.6%
Last Dividend: $0.76
Stock Price: $124.83
Stock Price: $124.83
Payout Ratio (Earnings paid out as dividends)
HEXDividends Paid / Net Income
12.6%
Dividends Paid: -$71.10M
Net Income: $566.20M
Net Income: $566.20M
Income Statement (Annual)
Last updated: Aug 13, 2026 6:28am (7h ago)| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | $5.1B | $4.3B | $4.8B | $5.4B | $5.9B |
| Cost of Revenue | — | — | — | — | — |
| Gross Profit | — | — | — | — | — |
| Operating Expenses | $4.3B | $3.7B | $4.1B | $4.5B | $4.9B |
| Operating Income | $559.6M | $539.5M | — | — | — |
| Net Income | $412.2M | $271.0M | $352.0M | $455.7M | $566.2M |
| EBITDA | $816.2M | $783.1M | — | — | — |
| EPS | $4.15 | $2.72 | $3.51 | $4.53 | $5.62 |
| EPS (Diluted) | $4.11 | $2.70 | $3.47 | $4.46 | $5.54 |
Balance Sheet (Annual)
Last updated: Aug 13, 2026 6:28am (7h ago)| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | $54.8M | $21.8M | $69.1M | $85.4M | $72.2M |
| Total Current Assets | $921.4M | $717.2M | $841.8M | $886.9M | $905.9M |
| Total Assets | $6.9B | $5.6B | $6.1B | $6.5B | $7.1B |
| Current Liabilities | $748.8M | $575.9M | $656.4M | $841.0M | $836.4M |
| Long-Term Debt | — | — | — | — | — |
| Total Liabilities | $4.5B | $3.8B | $3.8B | $3.7B | $3.8B |
| Total Equity | $2.4B | $1.9B | $2.3B | $2.8B | $3.3B |
| Retained Earnings | $141.8M | $115.7M | $406.5M | $796.7M | $1.3B |
Cash Flow (Annual)
Last updated: Aug 13, 2026 6:28am (7h ago)| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Operating Cash Flow | $715.8M | $705.8M | $850.8M | $1.0B | $1.2B |
| Capital Expenditure | -$545.7M | -$584.1M | -$583.1M | -$642.5M | -$736.4M |
| Free Cash Flow | $170.1M | $121.7M | $267.7M | $360.3M | $439.2M |
| Acquisitions (net) | -$118.6M | $0 | — | — | — |
| Net Debt Issued / (Repaid) | $0 | $11.8M | $20.0M | $15.0M | $0 |
| Dividends Paid | -$112.4M | -$99.0M | -$60.4M | -$62.8M | -$71.1M |
| Stock Buybacks | $0 | $0 | $0 | -$31.1M | -$158.0M |
| Net Change in Cash | -$190.6M | -$66.9M | $50.8M | $18.9M | -$20.2M |
Growth Trends (YoY %)
Last updated: Aug 13, 2026 6:28am (7h ago)| Metric | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Revenue Growth | -15.1% | +10.4% | +11.9% | +10.5% |
| Gross Profit Growth | — | — | — | — |
| Operating Income Growth | -3.6% | — | — | — |
| Net Income Growth | -34.3% | +29.9% | +29.5% | +24.2% |
| EBITDA Growth | -4.1% | — | — | — |
Dividend History (Last 20)
Last updated: Aug 13, 2026 6:28am (7h ago)| Date | Dividend | Declaration | Record | Payment |
|---|---|---|---|---|
| 2026-07-01 | $0.19 | — | — | — |
| 2026-04-01 | $0.19 | — | — | — |
| 2026-01-02 | $0.19 | — | — | — |
| 2025-10-01 | $0.19 | — | — | — |
| 2025-07-01 | $0.17 | — | — | — |
| 2025-04-01 | $0.17 | — | — | — |
| 2025-01-02 | $0.17 | — | — | — |
| 2024-10-01 | $0.17 | — | — | — |
| 2024-07-01 | $0.15 | — | — | — |
| 2024-03-28 | $0.15 | — | — | — |
| 2023-12-29 | $0.15 | — | — | — |
| 2023-09-29 | $0.15 | — | — | — |
| 2023-06-30 | $0.15 | — | — | — |
| 2023-03-31 | $0.15 | — | — | — |
| 2022-12-30 | $0.15 | — | — | — |
| 2022-09-30 | $0.15 | — | — | — |
| 2022-07-12 | $0.28 | — | — | — |
| 2022-03-31 | $0.22 | — | — | — |
| 2021-12-31 | $0.22 | — | — | — |
| 2021-09-30 | $0.22 | — | — | — |
Industry Benchmarks
Compares EHC against LLM-researched typical ranges for its
industry. One research call per industry, cached indefinitely — every stock in the same industry
reuses the same baseline.
Deep Analysis
Pre-flight intelligence scans the company first, then routes to the right analytical methods.
0
Company Classification
— What type of company is this?
1
Industry Landscape
— Where is the industry headed?
2
Company Momentum
— Where is this company trending?
3
Forward Projection
— 1Y & 2Y projected metrics (requires Layer 1 + 2)
4a
DCF Valuation
— Present value of future cash flows
4b
Earnings Power Value
— Floor value — worth with zero growth
4c
Anchored PE
— Industry PE adjusted for growth differential
4d
Reverse DCF
— What growth is the market pricing in?
4e
Revenue-Based DCF
— For growth/narrative companies (skip if mature earner)
4f
Anchored P/S
— Price-to-Sales peer comparison (skip if mature earner)
4g
Scenario Analysis
— Bull / Base / Bear (skip if mature earner)
4h
Dividend Discount Model
— For dividend/income stocks only
4i
Book Value Analysis
— For deep value / turnaround stocks only
4j
Insider Activity
— Are insiders buying or selling?
4f
Cash Flow Quality
— How trustworthy is the FCF?
4g
Debt Maturity Risk
— Can it handle its debt?
4h
Macro Environment
— Rates, market valuation, volatility
4i
Sector Intelligence
— How does this company compare within its sector?
4j
Revenue Confidence
— How reliable is the growth projection?
4k
Sensitivity Analysis
— How fragile is the fair value estimate?
4l
Sector Demand Cycle
— Is the sector in a boom, steady state, or contraction?
5
AI Investigation
— Adaptive research engine (Claude)
5b
Thesis Evaluation
— What does the market believe? (narrative/platform stocks only)
6
Valuation Synthesis
— Weighted verdict from all methods (requires Layer 4)
Narrative Economics
The story the market is telling about this stock — the intangible X-factor
(founder mythology, cult dynamics, TAM-of-imagination) that moves price beyond
what cash flows alone explain. After Shiller, Narrative Economics.
No narrative profile yet for EHC — it's generated by the pipeline (
market-narrative step).
Claude Reading
No AI findings yet for EHC — they're generated by the
pipeline (
ai-findings step) when a report is run on this ticker.
GPT Reading
No GPT reading yet for EHC — it's generated by the
pipeline (
gpt-critique step) after the other Big-3 seats, when a
report is run on this ticker.
Grok Reading
No Grok reading yet for EHC — it's generated by the
pipeline (
grok-critique step) alongside the other Big-3 seats, when a
report is run on this ticker.
Advanced Analysis Forensic deep-dive · four lenses
No community reviews yet for EHC.
Be the first — hit How to Contribute, have any AI review this page, and paste its take back here.
My Notes
personal — only you see this
Sign in to save personal notes and rate your interest in this stock.
Data via Financial Modeling Prep · Cached for performance · twelvedata
v1.1.530 · 761561a2 · 2026-08-12 19:06:35